Perioperative therapy for resectable and borderline resectable pancreatic adenocarcinoma: An AGICC clinical trial

被引：0
|
作者：
Cohen, Deirdre J.
Goldberg, Judith D.
Leichman, Lawrence P.
Hochman, Tsivia
Newman, Elliot
Du, Kevin Lee
Megibow, Alec
Oberstein, Paul Eliezer
Al-Rajabi, Raed Moh'd Taiseer
Scott, Aaron J.
Bekaii-Saab, Tanios S.
Messersmith, Wells A.
Weekes, Colin D.
机构：
[1] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA
[2] NYU, Grossman Sch Med, New York, NY USA
[3] NYU, Sch Med, New York, NY USA
[4] NYU Langone Hlth, Perlmutter Canc Ctr, New York, NY USA
[5] Northwell Hlth, New York, NY USA
[6] Yale Canc Ctr, New Haven, CT USA
[7] Univ Kansas, Med Ctr, Div Med Oncol, Kansas City, KS 66103 USA
[8] Univ Arizona, Tucson, AZ USA
[9] Mayo Clin, Comprehens Canc Ctr, Phoenix, AZ USA
[10] Univ Colorado, Aurora, CO USA
[11] Harvard Med Sch, Massachusetts Gen Hosp, Div Hematol Oncol, Dept Med, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4175
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Perioperative Chemotherapy and Chemoradiotherapy for Patients With Resectable and Borderline Resectable Pancreatic Adenocarcinoma
    Coveler, Andrew L.
    Pillarisetty, Venu G.
    Koh, Wui-Jin
    Zhen, David B.
    Park, James O.
    King, Gentry G.
    Sham, Jonathan G.
    Hannan, Lindsay M.
    Mann, Gary N.
    Baker, Kelsey K.
    Redman, Mary W.
    Swanson, Paul E.
    Chiorean, E. Gabriela
    Whiting, Sam H.
    PANCREAS, 2023, 52 (05) : E282 - E287
  • [2] A phase II study of perioperative therapy for patients with resectable and borderline-resectable pancreatic adenocarcinoma.
    Coveler, Andrew L.
    Pillarisetty, Venu Gopal
    Gyurkey, Grace
    Koh, Wui-Jin
    Upton, Melissa
    Cuevas, Carlos
    Gooley, Theodore
    Chiorean, E. Gabriela
    Shankaran, Veena
    Harris, William Proctor
    Park, James Oh
    Mann, Gary N.
    Byrd, David R.
    Balas, Stacey
    Whiting, Samuel H.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] Perioperative Therapy for Surgically Resectable Pancreatic Adenocarcinoma
    Du, Lingling
    DeFoe, Melissa
    Ruzinova, Marianna B.
    Olsen, Jeffrey R.
    Wang-Gillam, Andrea
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2015, 29 (04) : 717 - +
  • [4] Neoadjuvant Chemoradiation Therapy in Borderline Resectable Pancreatic Adenocarcinoma
    Shafi, S.
    Kaubisch, A.
    PANCREAS, 2015, 44 (08) : 1413 - 1413
  • [5] Borderline resectable pancreatic adenocarcinoma, is conversion therapy realistic?
    Kelly, Ciara M.
    El Bassiouni, Mazen
    Bennett, Michael W.
    Crush, Lee
    McEneaney, Peter
    O'Suilleabhain, Criostoir
    Power, Derek G.
    ACTA ONCOLOGICA, 2014, 53 (09) : 1268 - +
  • [6] Neoadjuvant Therapy for Resectable and Borderline Resectable Adenocarcinoma of the Pancreas
    Wolff, Robert A.
    CURRENT DRUG TARGETS, 2012, 13 (06) : 781 - 788
  • [7] Advances in Borderline Resectable Pancreatic Adenocarcinoma
    Vadehra, Deepak
    Salibi, Patrick N.
    McHaffie, Derek R.
    Sulzer, Jesse
    Iannitti, David A.
    Hwang, Jimmy J.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (05) : 280 - 288
  • [8] Management of Borderline Resectable Pancreatic Adenocarcinoma
    Jia, Yuxia
    Wang, Tony J. C.
    Allendorf, John
    Saif, Muhammad Wasif
    JOURNAL OF THE PANCREAS, 2012, 13 (02): : 147 - 150
  • [9] Perioperative Therapy for Borderline Resectable Pancreatic Cancer: What and When?
    Michael P. Kim
    Matthew H. G. Katz
    Annals of Surgical Oncology, 2019, 26 : 1596 - 1597
  • [10] Perioperative Therapy for Borderline Resectable Pancreatic Cancer: What and When?
    Kim, Michael P.
    Katz, Matthew H. G.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (06) : 1596 - 1597
12345